Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSULIN-PH20 NP vs Insulin Lispro in Type 1 Diabetes
NCT00883558Phase 2Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- May 2009
- Primary completion
- Feb 2010
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin, hyaluronidase in type 1 diabetes mellitus (T1D), sponsored by Halozyme Therapeutics, Inc.. Started May 2009; status: completed.
02
Drugs
human insulinhyaluronidase
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00883558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883558.